These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26227883)

  • 21. De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease.
    Motley WW; Palaima P; Yum SW; Gonzalez MA; Tao F; Wanschitz JV; Strickland AV; Löscher WN; De Vriendt E; Koppi S; Medne L; Janecke AR; Jordanova A; Zuchner S; Scherer SS
    Brain; 2016 Jun; 139(Pt 6):1649-56. PubMed ID: 27009151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The function of the Periaxin gene during nerve repair in a model of CMT4F.
    Williams AC; Brophy PJ
    J Anat; 2002 Apr; 200(4):323-30. PubMed ID: 12090399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The EGR2 gene is involved in axonal Charcot-Marie-Tooth disease.
    Sevilla T; Sivera R; Martínez-Rubio D; Lupo V; Chumillas MJ; Calpena E; Dopazo J; Vílchez JJ; Palau F; Espinós C
    Eur J Neurol; 2015 Dec; 22(12):1548-55. PubMed ID: 26204789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel pathogenic copy number variations in Charcot-Marie-Tooth disease.
    Mortreux J; Bacquet J; Boyer A; Alazard E; Bellance R; Giguet-Valard AG; Cerino M; Krahn M; Audic F; Chabrol B; Laugel V; Desvignes JP; Béroud C; Nguyen K; Verschueren A; Lévy N; Attarian S; Delague V; Missirian C; Bonello-Palot N
    J Hum Genet; 2020 Mar; 65(3):313-323. PubMed ID: 31852984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Mutation in PMP2 Causes Dominant Demyelinating Charcot-Marie-Tooth Neuropathy.
    Hong YB; Joo J; Hyun YS; Kwak G; Choi YR; Yeo HK; Jwa DH; Kim EJ; Mo WM; Nam SH; Kim SM; Yoo JH; Koo H; Park HT; Chung KW; Choi BO
    PLoS Genet; 2016 Feb; 12(2):e1005829. PubMed ID: 26828946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild phenotype of Charcot-Marie-Tooth disease type 4B1.
    Murakami T; Kutoku Y; Nishimura H; Hayashi M; Abe A; Hayasaka K; Sunada Y
    J Neurol Sci; 2013 Nov; 334(1-2):176-9. PubMed ID: 23962696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families.
    Nicholson G; Nash J
    Neurology; 1993 Dec; 43(12):2558-64. PubMed ID: 8255457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease).
    Berger P; Niemann A; Suter U
    Glia; 2006 Sep; 54(4):243-57. PubMed ID: 16856148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
    Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
    Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four novel cases of periaxin-related neuropathy and review of the literature.
    Marchesi C; Milani M; Morbin M; Cesani M; Lauria G; Scaioli V; Piccolo G; Fabrizi GM; Cavallaro T; Taroni F; Pareyson D
    Neurology; 2010 Nov; 75(20):1830-8. PubMed ID: 21079185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-linked dominant Charcot-Marie-Tooth neuropathy: clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations(1).
    Senderek J; Hermanns B; Bergmann C; Boroojerdi B; Bajbouj M; Hungs M; Ramaekers VT; Quasthoff S; Karch D; Schröder JM
    J Neurol Sci; 1999 Aug; 167(2):90-101. PubMed ID: 10521546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Charcot-Marie-Tooth disease associated with periaxin mutations (CMT4F): Clinical, electrophysiological and genetic analysis of 24 patients].
    Renouil M; Stojkovic T; Jacquemont ML; Lauret K; Boué P; Fourmaintraux A; Randrianaivo H; Tallot M; Mignard D; Roelens P; Tabailloux D; Bernard R; Cartault F; Chane-Thien E; Dubourg O; Ferrer X; Sole G; Fournier E; Latour P; Lacour A; Mignard C
    Rev Neurol (Paris); 2013; 169(8-9):603-12. PubMed ID: 24011642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole exome sequencing revealed a novel dystrophin-related protein-2 (
    Tahmasebi-Birgani M; Hajjari M; Golchin N; Shalbafan B; Mohammadi-Asl J; Sadeghian F
    Iran J Basic Med Sci; 2019 May; 22(5):576-580. PubMed ID: 31217940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linkage analysis and whole exome sequencing reveals AHNAK2 as a novel genetic cause for autosomal recessive CMT in a Malaysian family.
    Tey S; Shahrizaila N; Drew AP; Samulong S; Goh KJ; Battaloglu E; Atkinson D; Parman Y; Jordanova A; Chung KW; Choi BO; Li YC; Auer-Grumbach M; Nicholson GA; Kennerson ML; Ahmad-Annuar A
    Neurogenetics; 2019 Aug; 20(3):117-127. PubMed ID: 31011849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton.
    Fabrizi GM; Cavallaro T; Angiari C; Cabrini I; Taioli F; Malerba G; Bertolasi L; Rizzuto N
    Brain; 2007 Feb; 130(Pt 2):394-403. PubMed ID: 17052987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy.
    Züchner S; Vorgerd M; Sindern E; Schröder JM
    Neuromuscul Disord; 2004 Feb; 14(2):147-57. PubMed ID: 14733962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological findings in the x-linked form of Charcot-Marie-Tooth disease: a morphometric and ultrastructural analysis.
    Hahn AF; Ainsworth PJ; Bolton CF; Bilbao JM; Vallat JM
    Acta Neuropathol; 2001 Feb; 101(2):129-39. PubMed ID: 11271367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study.
    Ando M; Hashiguchi A; Okamoto Y; Yoshimura A; Hiramatsu Y; Yuan J; Higuchi Y; Mitsui J; Ishiura H; Umemura A; Maruyama K; Matsushige T; Morishita S; Nakagawa M; Tsuji S; Takashima H
    J Peripher Nerv Syst; 2017 Sep; 22(3):191-199. PubMed ID: 28660751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B.
    Saporta MA; Shy BR; Patzko A; Bai Y; Pennuto M; Ferri C; Tinelli E; Saveri P; Kirschner D; Crowther M; Southwood C; Wu X; Gow A; Feltri ML; Wrabetz L; Shy ME
    Brain; 2012 Jul; 135(Pt 7):2032-47. PubMed ID: 22689911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.